What PRO-Spectus does

PRO-Spectus is a privately held healthcare advisory firm headquartered in San Diego, California, founded in 2008 by Charmie E. Chirgwin, RN, who continues to serve as CEO. The company operates as a B2B services provider targeting pharmaceutical companies, medical device manufacturers, and diagnostic firms, helping these manufacturers navigate the complex journey between product commercialization and patient access. PRO-Spectus serves its clients through six integrated service modules: Patient Support Services (benefit investigation, prior authorization, appeals management), Market Access (launch roadmap, coverage and reimbursement strategy, value analysis), Reimbursement Support (revenue cycle management, credentialing, claims operations), Policy Strategy (market analysis, data and reporting, coverage expansion), Affordability (copay support, patient assistance programs, bridge coverage), and Adherence (clinical education, adherence modeling, patient registries).

The firm's technology stack includes electronic benefits verification (eBV), electronic prior authorization (ePA), a CRM system with bi-directional supplier and distributor feeds, AI-enabled automations for workflow streamlining, and real-time dashboard reporting for healthcare providers and manufacturer field sales teams. These tools are applied across the patient access workflow rather than offered as standalone products.

PRO-Spectus generates revenue through professional services engagements under flexible, tailored partnership arrangements with healthcare manufacturer clients, with pricing not publicly disclosed. The company employs 51-100 staff, supported by a 10-person executive leadership team including functional C-suite roles across innovation, digital transformation, operations, finance, and people. The firm was recognized on the Inc. 5000 list of America's fastest-growing private companies and earned Great Place to Work certification for 2026, and received institutional growth capital from Shore Capital Partners in April 2024. The company operates exclusively in the United States.

Name

PRO-Spectus

Legal name

PRO-Spectus

Website

https://pro-spectus.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

PRO-Spectus is a US-based healthcare advisory firm that provides patient access, market access, reimbursement, policy strategy, affordability, and adherence services to pharmaceutical, medical device, and diagnostic manufacturers. It operates through six integrated service modules supported by AI-enabled automation technology.

Ownership category

akta.pro rank

Product category

Healthcare Market Access Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

Keywords

• Healthcare market access
• Patient support services
• Reimbursement support
• Medical policy strategy
• Prior authorization services

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Patient Support Services: Comprehensive patient support services including benefit investigation, prior authorization, affordability solutions, and adherence support for pharmaceutical, medical device, and diagnostic manufacturers.
2. Market Access Consulting: Strategic consulting services for coding, coverage, and payment navigation across the continuum of care, including launch roadmap, partnership education, and value analysis support.
3. Reimbursement Support & Revenue Cycle Management: Revenue cycle management services including claims operations, credentialing, contract management, charge entry review, payment posting, and financial reporting.
4. Policy Strategy Services: Medical policy strategy services including market analysis, data and reporting, and coverage and policy expansion support to improve industry acceptance of treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

PRO-Spectus is a patient access solutions company that delivers B2B advisory, reimbursement, and patient support services to pharmaceutical, medical device, and diagnostic manufacturers. Its core offering spans six integrated modules—Patient Support Services, Market Access, Reimbursement Support, Policy Strategy, Affordability, and Adherence—covering benefit investigation, prior authorization, coding/coverage/payment strategy, revenue cycle management, policy expansion, and clinical adherence. Services are delivered by domain experts supported by a proprietary technology platform with AI-enabled automations, electronic benefits verification, electronic prior authorization, and CRM-based reporting.

Product overview

PRO-Spectus is a patient access solutions company offering a platform of interconnected services designed to help pharmaceutical companies, medical device manufacturers, and diagnostic firms expand access to specialized products. The core offering consists of six integrated service modules: Patient Support Services (covering benefit investigation, prior authorization, affordability, adherence, and appeals management), Market Access (covering launch roadmap, partnership, coverage and reimbursement strategy, and value analysis), Reimbursement Support (covering revenue cycle management, credentialing, and claims operations), Policy Strategy (covering market analysis, data and reporting, and coverage expansion), Affordability (covering supplemental care, copay support, patient assistance programs, and bridge coverage), and Adherence (covering clinical education, adherence modeling, and patient registry infrastructure). These services work together to simplify the complex journey from product development to patient access.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Support Services Comprehensive patient services programs that help patients navigate coverage, out-of-pocket responsibility, and prior authorization processes for pharmaceutical, medical device, and diagnostic products. Aimed at manufacturer clients seeking to expand access to specialized therapies.
• Market Access Strategic consulting services that help pharmaceutical companies, medical device manufacturers, and diagnostic firms navigate coding, coverage, and payment across the continuum of care, including launch roadmap, partnership and education, coverage and reimbursement strategy, and value analysis.
• Reimbursement Support Revenue cycle management services encompassing RCM infrastructure design, credentialing and contract management, and claims operations to optimize reimbursement and resolve claims complexities for healthcare manufacturers.
• Policy Strategy Medical policy improvement services that help clients accelerate industry acceptance and adoption of treatment through market analysis, data and reporting, and coverage and policy expansion.
• Affordability Solutions to support patient affordability including supplemental care for transit, meals, lodging and ancillary expenses; copay support for pharmacy and medical benefit products; patient assistance programs; and bridge support for patients experiencing coverage gaps.
• Adherence Clinical support services including early education, targeted adherence programs, clinical outcomes measurement, clinical education, adherence modeling, and patient registry infrastructure to identify and address barriers to patient care.

Quantifiable outcome

• High prior authorization approval rate (specific percentage displayed on homepage)
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• EVERSANA: EVERSANA is a large, established commercial services firm providing market access, patient services, reimbursement, and policy solutions to life sciences manufacturers. Directly comparable to PRO-Spectus across all six of PRO-Spectus's service modules, but at significantly greater scale and global footprint.
• Lash Group (Cencora): Lash Group, a Cencora (formerly AmerisourceBergen) company, is a leading patient support services hub provider offering benefit verification, prior authorization, affordability, and adherence programs to pharma manufacturers. Directly comparable to PRO-Spectus's Patient Support Services module and operates at much larger scale as part of a Fortune 10 distributor.
• IQVIA: IQVIA is the largest life sciences services and data firm, offering market access consulting, patient engagement, real-world evidence, and policy strategy globally. Overlaps substantially with PRO-Spectus's offerings but at vastly greater scale and as part of a much broader portfolio.
• Syneos Health: Syneos Health provides clinical and commercial services to biopharma, including patient access, market access, and reimbursement support. Comparable to PRO-Spectus on the commercial services side while also operating a much larger CRO business.

Direct peers

• ConnectiveRx: ConnectiveRx provides patient access, adherence, and affordability solutions (including hub services, copay programs, and prior authorization support) to pharma manufacturers. Closely aligned with PRO-Spectus's patient support and affordability offerings, with similar mid-market positioning and similar target customer base.
• CareMetx: CareMetx is a patient access and hub services provider for specialty therapies, offering electronic benefit verification, prior authorization, financial assistance, and adherence support. Highly comparable to PRO-Spectus on patient support services for specialty pharma and medical device manufacturers.
• Precision Medicine Group (PRECISIONvalue): Precision Medicine Group, including its PRECISIONvalue and PRECISIONheor units, delivers market access consulting, reimbursement strategy, and HEOR services to pharma/biotech manufacturers. Directly comparable to PRO-Spectus's Market Access and Policy Strategy offerings, particularly for specialty and rare disease products.
• Lumanity: Lumanity is a life sciences consulting firm specializing in market access, pricing, reimbursement, and health economics for pharma and medtech clients. Comparable to PRO-Spectus's Market Access and Policy Strategy services with similar boutique consulting positioning.
• Beghou Consulting: Beghou Consulting is a life sciences consulting firm focused on commercial analytics, market access, and pricing/reimbursement strategy for pharma/biotech manufacturers. Closely aligned with PRO-Spectus's market access and reimbursement consulting offerings and similar mid-size boutique positioning.

Others

• Veeva Systems: Veeva Systems provides cloud-based software (CRM, Veeva Vault, etc.) to life sciences companies, including market access and patient services technology. While not a direct services competitor, Veeva is an enabling technology peer whose commercial cloud platform competes conceptually with PRO-Spectus's proprietary AI/CRM platform.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pro-spectus

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PRO-Spectus